Cumberland Pharmaceuticals CPIX
NASDAQ CPIX
$7.51 -0.32 (-4.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cumberland Pharmaceuticals (CPIX) Non Operating Interest Expenses (2010 - 2026)

Updated

Cumberland Pharmaceuticals (CPIX) posted Non Operating Interest Expenses of $724.00 for Q2 2026, up 53.7% from $471.00 a year earlier but down 99.2% from the prior quarter.

Analysis

Cumberland Pharmaceuticals (CPIX) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Cumberland Pharmaceuticals was $309,204, down 41.1% year-over-year; for FY2025, it was $495,990, down 18.1% from FY2024.

  • Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of 13.5% (FY2020 to FY2025).
  • In prior years, Cumberland Pharmaceuticals' Non Operating Interest Expenses was $605,508 in FY2024 (-9.3%), $667,861 in FY2023 (+14.0%), $585,995 in FY2022 (+497.8%) and $98,031 in FY2021 (-62.8%).
  • Quarterly Non Operating Interest Expenses has run from a low of $471.00 in Q2 2025 to a high of $223,261 in Q4 2024 over five years.
  • On a year-over-year basis, Non Operating Interest Expenses increased in four of the last eight quarters, with an average decline of 9.4%.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q3 2022, with growth of 645.9%; the weakest was Q2 2025, with a decline of 99.6%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $85,839 (Q1 2026), $112,942 (Q4 2025) and $109,699 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cumberland Pharmaceuticals 117.32 Mn 75.48 Mn - 724.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 724.00
Mar 31, 2026 85,839.00
Dec 31, 2025 112,942.00
Sep 30, 2025 109,699.00
Jun 30, 2025 471.00
Mar 31, 2025 163,802.00
Dec 31, 2024 223,261.00
Sep 30, 2024 137,374.00
Jun 30, 2024 126,347.00
Mar 31, 2024 118,526.00
Dec 31, 2023 178,792.00
Sep 30, 2023 110,081.00
Jun 30, 2023 192,635.00
Mar 31, 2023 186,353.00
Dec 31, 2022 179,456.00
Sep 30, 2022 149,340.00
Jun 30, 2022 137,624.00
Mar 31, 2022 119,575.00
Dec 31, 2021 27,734.00
Sep 30, 2021 20,021.00
API Access

Cumberland Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CPIX&period=max&api_key=YOUR_API_KEY